<< Back to Epigenetics on Target Home Page

Bromodomains in Epigenetics and Disease

Bromodomains are evolutionarily conserved protein modules that recognize and bind to acetylated lysine residues, primarily on histone tails. This binding allows bromodomain-containing proteins to function as epigenetic "readers", helping to regulate gene expression, chromatin structure, and transcriptional activation. Many of these proteins play central roles in transcriptional coactivation, chromatin remodeling, or histone acetylation, and are frequently implicated in cancer, neurological disorders, and inflammatory diseases. Notably, BET family proteins (BRD2, BRD3, BRD4, BRDT) are the most well-characterized, with BRD4 emerging as a high-value drug target in oncology. Other bromodomain proteins such as CBP/p300, SMARCA4, and PBRM1 also serve as tumor suppressors or oncogenic cofactors, making them crucial to understanding and manipulating epigenetic regulation in disease.

Protein / Family Epigenetic Function Disease Association Key Publications Key Products
ATAD2 Binds acetylated histones; oncogenic co-activator for MYC Breast, liver, lung cancers Biju et al., Int J Biol Macromol. 2025
Han et al., Blood. 2025

Antibodies

BAZ1B (WSTF) Chromatin assembly, transcription regulation, DNA repair Williams-Beuren syndrome Pai et al., Dev Biol. 2024
Kim et al., Nat Commun. 2024
 
BRD1 Component of the MOZ/MORF HAT complex; interacts with acetylated histones; coactivates nuclear receptors; regulates gene expression during development Schizophrenia, bipolar disorder, depression, and some cancers (e.g. breast) Zhang et al., Cell Death Dis. 2025
Wang et al., Sci Transl Med. 2024

Proteins

BRD2 (BET) Transcriptional regulation; binds acetylated histones Obesity, epilepsy, B-cell lymphoma Wang et al., Biochem J. 2009
Pathak et al., Epilepsia 2018
Zou et al., Cell Biosci. 2024

Antibodies

Proteins

BRD3 (BET) Chromatin binding; transcriptional regulation NUT midline carcinoma (BRD3-NUT fusion) Hwang et al., Diagn Cytopathol. 2023
Hashimoto et al., Cancer Sci. 2024

Antibodies

Proteins

BRD4 (BET) Recognizes acetyl-H3/H4; recruits P-TEFb for transcriptional elongation AML, NUT carcinoma, breast cancer, inflammation Umphred-Wilson et al., Nat Commun. 2025
Fan et al., Nat Commun. 2025
Zhang et al., Cell Rep. 2024
Cameron et al., Sci Adv. 2023

Antibodies

Proteins

BRD7 Part of PBAF; cofactor of p53; chromatin remodeling Breast, colorectal cancer Mondal et al., Nat Commun. 2025
Guo et al., Int J Biol Sci. 2025

Antibodies

Proteins

BRD8 Part of the NuA4/TIP60 histone acetyltransferase complex; binds acetylated histones and regulates DNA repair, chromatin remodeling, and transcription Overexpressed in colorectal and hepatocellular carcinomas; potential role in tumor progression and chromatin instability Wu et al., Eur J Med Chem. 2024
Yamaguchi et al., Cancer Sci. 2024

Proteins

BRD9 Non-BET; part of ncBAF SWI/SNF complex AML, multiple myeloma Lee et al., Nuc Acids Res. 2025
Lv et al., Cell Death Dis. 2025

Antibodies

Proteins

BRDT (BET) Testis-specific; chromatin remodeling in spermatogenesis Male infertility; contraceptive target F. Pietra, Chemistry Europe 2024
Zheng et al., Sci Adv. 2025

Proteins

CBP (CREBBP) Histone acetyltransferase; bromodomain recognizes acetyl marks Rubinstein-Taybi syndrome, lymphomas Chen et al., J Neuropathol Exp Neurol. 2025
Liu et al., bioRxiv 2025

Antibodies

Proteins

Kits

p300 (EP300) Transcription coactivator and HAT; acetylates histones and TFs Colorectal, bladder, and hematological cancers Sasaki et al., Nat Commun. 2024
Xu et al., Acta Neuropathol Commun. 2024
Compton et al., Mol Cell 2023

Antibodies

Proteins

PBRM1 Contains 6 bromodomains; tumor suppressor in PBAF complex Clear cell renal cell carcinoma Lane et al., Nat Commun. 2025
Yao et al., Nat Cell Biol. 2023
Petell et al., J Biol Chem. 2023

Antibodies

Proteins

SMARCA1 (SNF2L1) ISWI-family chromatin remodeler; regulates nucleosome spacing and compaction; modulates gene accessibility during differentiation Dysregulated in glioma, prostate, and other cancers; implicated in neuronal development and X-inactivation escape Nishimura et al., J Hum Genet. 2025
Fu et al., bioRxiv 2024

Antibodies

SMARCA2 (BRM) Similar to SMARCA4; SWI/SNF remodeling Silenced in lung and other cancers Papavassiliou et al., Trends Cancer. 2025
Guo et al., Eur J Med Chem. 2025
Deng et al., Pathol Res Pract. 2025

Antibodies

Proteins

SMARCA4 (BRG1) ATPase in SWI/SNF complex; chromatin remodeling Lung, ovarian, pediatric brain cancers Ye et al., Cancer Lett. 2025
Wang et al., Cancer Res. 2025
Papavassiliou et al., Trends Cancer. 2025

Antibodies

Proteins

SMARCAL1 / HARP Chromatin-associated annealing helicase; stabilizes stalled replication forks; aids chromatin structure restoration after replication stress Causative mutations in Schimke Immuno-Osseous Dysplasia (SIOD); linked to genome instability in cancer and DNA damage response defects Oak et al., medRxiv 2025
Zhao et al., Sci Rep. 2025

Antibodies

TAF1 TFIID subunit; bromodomains recognize acetylated promoters X-linked dystonia-parkinsonism Chen et al., Mol Cancer Ther. 2025
Burgos et al., bioRxiv 2025

Proteins

 

Additional Resources